Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by str8tgoodson Oct 22, 2010 10:03am

473 Views

Post# 17597545

RE: Stuck at 19.5 cents

Well looks like some aren't willing to wait for results, and some are taking a position.

I guess that the short term traders aren't willing to wait a couple weeks, but I've seen companies have serious runups and downs of course, prior to releasing results, so this can go either way.

I'm waiting for results and hoping for the best. Likewise with ALE.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!